## Abstract The purpose of our study was to prospectively evaluate cardiac [^123^I]metaiodobenzylguanidine (MIBG) uptake in patients with cerebrovascular disease (CVD) who develop clinical symptoms of vascular Parkinsonism (VP). A total of 19 consecutive patients who developed Parkinsonism during t
Cardiac 123 I-metaiodobenzylguanidine scintigraphy in elderly depressed patients
β Scribed by Fujishiro, Hiroshige
- Book ID
- 121758877
- Publisher
- John Wiley and Sons
- Year
- 2014
- Tongue
- English
- Weight
- 30 KB
- Volume
- 68
- Category
- Article
- ISSN
- 1323-1316
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Autonomic dysfunction is common in Lewy body disorders (Parkinson's disease, Dementia with Lewy Bodies, Pure Autonomic Failure, and REM sleep disorder). The loss of postβganglionic myocardial sympathetic nerve fibers is a prominent feature of autonomic dysfunction in such disorders. ^12
In some cases, it is difficult to differentiate essential tremor (ET) from Parkinson's disease (PD), especially in the early stages of the disease. We investigated cardiac sympathetic dysfunction using (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy in 22 patients with ET, in compariso
Although we are sympathetic to Reynolds and Slocum's concerns, 1 their editorial errs on several points. The authors cite deference to regulatory (presumably Food and Drug Administration) approval as a constraint. The FDA has long recognized broad physician discretion in using FDAapproved drugs or d